Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guben Kechuan granules real-world study in stable chronic obstructive pulmonary disease
ChiCTR2300078017Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Guben Kechuan in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Frequency of acute exacerbation of chronic obstructive pulmonary disease during the observation period. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Guben Kechuan
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2300078017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078017.